Summary
The concentration of 5-methoxypsoralen (5-MOP) in suction blister fluid (SBF) after oral intake was determined in relation to the peak blistering point. Interstitial fluid was obtained from nine healthy male volunteers by applying mild suction (300–350 mmHg) to the skin of the volar aspect of the forearm. Blisters were raised at three different times: 18 h prior to drug administration (group I); 2 h prior to drug administration (group II); and during drug ingestion (group III). SBF levels of 5-MOP were determined in each group of blisters 2 h after oral administration of 1.2 mg/kg micronized 5-MOP. The results showed a statistically significant difference in the concentrations of 5-MOP between each group of blisters. The highest concentration of 5-MOP in the SBF was found in group III and the lowest in group II blisters. These findings suggest that the point of peak blistering in relation to drug administration needs to be known in each pharmacological study using suction blisters.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Averbeck D, Averbeck S, Blais J, Moysan A, Hüppe G, Morliere P, Prognon P, Vigny P, Dubertret L (1989) Suction blister fluid: its use for pharmacodynamic and toxicological studies of drugs and metabolites in vivo in human skin after topical or systemic administration. In: Maibach HI, Lowe NJ (eds) Models in dermatology, vol. 4. Karger, Basel, pp 5–11
Herfst MJ, Edelbroek PM, de Wolff FA (1980) Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography. Clin Chem 26:1825–1828
Khaldoun H, Makki S, Treffel P, Humbert P, Agache P, Guinchard C (1990) Higher bioavailability of a new oral 5-methoxypsoralen formulation. J Invest Dermatol 94:398
Kiistala U (1968) Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 50:129–137
Kiistala U (1972) Dermal-epidermal separation. The influence of age, sex and body region on suction blister formation in human skin. Ann Clin Res 4:10–22
Lauharanta J, Juvakoski T, Kanerva L, Lassus A (1982) Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. Arch Dermatol Res 273:111–114
Meinardi MMHM, Van Eendenburg JP, Costing J, Van Boxtel CJ, De Rie MA, Bos JD (1990) Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically. Br J Dermatol 122:671–676
Oikarinen A, Savolainen ER, Tryggvason K, Foidart JM, Kiistala U (1982) Basement membrane components and galactosylhydroxylysyl glucosyl-transferase in suction blisters of human skin. Br J Dermatol 106:257–266
Reymond JL, Beani JC, Racinet H, Bonnot D, Beriel H, Amblard P (1988) Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid. Photodermatology 5:51–52
SchÄfer-Korting M, Grimm HW, Mutschler E (1985) Morphologische, biochemische und pharmakokinetische Untersuchungen an Saugblasen in AbhÄngigkeit von der Art und dem Zeitpunkt ihrer Entstehung. Arch Pharm (Weinheim) 318:711–720
SchÄfer-Korting M, Korting HC, Lukacs A, Heykants J, Behrendt H (1990) Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. J Am Acad Dermatol 22:211–215
Stolk LML, Westerhof W, Cormane RH, Van Zwieten PA (1981) Serum and urine concentrations of 5-methoxypsoralen after oral administration. Br J Dermatol 105:415–420
Tanew A, Ortel B, Rappersberger K, Hönigsmann H (1988) 5-methoxypsoralen (Bergapten) for photochemotherapy. J Am Acad Dermatol 18:333–338
Wise R (1986) Methods for evaluating the penetration of Β-lactam antibiotics into tissues. Rev Infect Dis 8 [Suppl 3]:325–332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Humbert, P., Treffel, P., Makki, S. et al. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration. Arch Dermatol Res 283, 297–299 (1991). https://doi.org/10.1007/BF00376617
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00376617